Geographically, the global hyperpigmentation disorder treatment market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, Asia Pacific dominated the hyperpigmentation disorder treatment market share in 2022. The hyperpigmentation disorder treatment market in this region is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. India dominated the market in Asia Pacific. This can be attributed to various factors, including the increasing number of patients experiencing hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation (PIH), leading to an increase in the research and development of new treatments and medications.
Additionally, the presence of major companies—such as L’Oréal S.A., Galderma S.A., and Bayer AG—and the availability of technological innovations—such as laser therapies—contribute to the market growth in the region. Furthermore, the increasing government healthcare spending creates opportunities for further market growth.
Rising Number of Hyperpigmentation Disorders Fuels Hyperpigmentation Disorder Treatment Market Growth
Hyperpigmentation disorders such as melasma, PIH, and solar lentigines (age spots) are common dermatological conditions that cause hyperpigmentation in individuals with pigmented skin (Blacks, mixed ancestry, Indians, Hispanics, and African Americans). According to an article published by the Royal Australian College of General Practitioners in December 2021, melasma affects ~1% of the global population. However, people with darker skin types (III-V) are more likely to develop it. The prevalence rate in people of Latin American, Southeast Asian, and South Asian ethnicity can be as high as 40%.
Hyperpigmentation disorders have a significant impact on the mental and social well-being of the patients, owing to which there is a significant consumer demand for skin-lightening cosmetic products.
Therefore, as the prevalence of hyperpigmentation disorders continues to rise globally, the demand for skin-lightening agents as a widely accessible treatment option contributes significantly to boost the hyperpigmentation disorder treatment market growth.
Factors Restraining Market Growth:
With the growing accessibility of emerging technologies for the treatment of hyperpigmentation disorders, the cost of aesthetic procedures is also increasing. According to the American Society of Plastic Surgeons (ASPS), non-ablative laser therapy costs around US$ 1,031, while ablative treatments cost approximately US$ 2,330 per session. Additionally, the frequent use of laser and light-based equipment may cause PIH, which can make the skin vulnerable. However, a lack of reimbursement from insurance firms for skin restoration methods can limit the use of these procedures and hinder market growth.
Hyperpigmentation Disorder Treatment Market: Segmental Overview
Based on treatment type, the hyperpigmentation disorder treatment market is segmented into cosmeceutical, chemical peel, cryotherapy, light or laser therapy, microdermabrasion, and others. The cosmeceutical segment held the largest market share in 2022. The microdermabrasion segment is anticipated to register the highest CAGR during 2022–2030.
The market, by disease type, is segmented into age spots, melasma, post inflammatory, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. The post-inflammatory segment is anticipated to grow at the fastest CAGR from 2022 to 2030.
Based on end users, the hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022. This can be attributed to the provision of better facilities and more skilled physicians than in clinics to perform minimally invasive procedures. Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.
Geographically, the hyperpigmentation disorder treatment market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Hyperpigmentation Disorder Treatment Market: Competitive Landscape and Key Developments
Abbvie Inc. (Allergen, Inc.), Bayer AG, Epipharm AG, Galderma Laboratories, Obagi Cosmeceuticals LLC., Lutronic Corporation, La Pristine, La Roche-Posay, Pierre Fabre Group, and Vivier Pharma USA are among the key companies profiled in the hyperpigmentation disorder treatment market report. These companies focus on technological advancements to present new hi-tech products in their product portfolios and geographic expansions to meet the growing consumer demand worldwide, which allows them to maintain their brand name in the global hyperpigmentation disorder treatment market.
A few of the recent developments in the global hyperpigmentation disorder treatment market are mentioned below:
- In January 2023, Allergan Aesthetics, a subsidiary of AbbVie company, launched the SkinMedica Even & Correct Collection. This collection includes advanced brightening and dark spot reduction cream and brightening treatment pads formulated with ultra-concentrated lotus sprout extract, tranexamic acid, and niacinamide.
- In October 2022, Galderma launched Alastin Skincare A-Luminate Brightening Serum, a novel formulation developed to reduce hyperpigmentation. This serum is a multifaceted blend of peptides, antioxidants, and targeted ingredients and contains ALASTIN’s PATH-3 Technology that helps minimize surface pigmentation and protects against future damage.
- In February 2022, Restorative Elements, one of the skincare brands of Alchemee LLC, launched its first Restorative Routine Kit. This kit is a clinically proven regimen developed by dermatologists that gently and safely helps fade the visible signs of skin hyperpigmentation. This routine focuses on correcting skin hyperpigmentation and discoloration, including sunspots, age spots, PIH, and uneven skin tone.